BRCA1 and BRCA2 mutations and clinical interpretation in 398 ovarian cancer patients: comparison with breast cancer variants in a similar population

BACKGROUND: Ovarian cancer is the leading cause of death worldwide among gynecologic malignancies. The recent approval of inhibitors of poly (ADP-ribose) polymerase (iPARP) in the treatment of ovarian cancer in the presence of a BRCA1/2 mutation has sparked the analysis of women with such diagnosis,...

Descripción completa

Detalles Bibliográficos
Autores principales: Cardoso, Florencia C., Goncalves, Susana, Mele, Pablo G., Liria, Natalia C., Sganga, Leonardo, Diaz Perez, Ignacio, Podesta, Ernesto J., Solano, Angela R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Primary Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6090818/
https://www.ncbi.nlm.nih.gov/pubmed/30103829
http://dx.doi.org/10.1186/s40246-018-0171-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6090818/
https://www.ncbi.nlm.nih.gov/pubmed/30103829
http://dx.doi.org/10.1186/s40246-018-0171-5

Ejemplares similares